![Angus Russell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Angus Russell
Directeur/Membre du Conseil chez
LINEAGE CELL THERAPEUTICS, INC.
Fortune : 116 375 $ au 31/05/2026
Profil
Mr. Angus C.
Russell is an Independent Director at Structure Therapeutics, Inc. and an Independent Director at Lineage Cell Therapeutics, Inc. He is on the Board of Directors at Structure Therapeutics, Inc. and Lineage Cell Therapeutics, Inc. Mr. Russell was previously employed as an Independent Director by TherapeuticsMD, Inc., a Chairman by Mallinckrodt Plc, a Non-Executive Chairman by Revance Therapeutics, Inc., an Independent Director by InterMune, Inc., a Non-Executive Director by The City of London Investment Trust Plc, a Chief Executive Officer & Director by Shire Plc, a Chief Financial Officer by Shire Plc /Old/, a Vice President-Corporate Finance by AstraZeneca PLC, a Principal by Imperial Chemical Industries Plc, a Treasurer by Zeneca Garden Care, a Non-Executive Director by Investment Trust Ltd., and a Chief Financial Officer & Director by Shire Acquisition, Inc. He also served on the board at Questcor Pharmaceuticals, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 87 500 ( 0,04 % ) | 116 375 $ | 31/05/2026 | |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Angus Russell
| Sociétés | Poste | Début |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 09/12/2014 |
| STRUCTURE THERAPEUTICS INC. | Directeur/Membre du Conseil | 26/08/2024 |
Anciens postes connus de Angus Russell
| Sociétés | Poste | Fin |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | Président | 04/02/2025 |
| THERAPEUTICSMD, INC. | Directeur/Membre du Conseil | 30/12/2022 |
| MALLINCKRODT PLC | Président | 16/06/2022 |
| INTERMUNE INC | Directeur/Membre du Conseil | 01/09/2014 |
| QUESTCOR PHARMACEUTICALS INC | Directeur/Membre du Conseil | 14/08/2014 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Imperial Chemical Industries Ltd.
 Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and paint products | Process Industries |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Shire Acquisition, Inc.
 Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
The City of London Investment Trust Plc
 The City of London Investment Trust Plc Financial ConglomeratesFinance Functions as a closed-end investment fund or Investment trust | Finance |
Zeneca Garden Care
 Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
Investment Trust Ltd. | |
TherapeuticsMD, Inc.
 TherapeuticsMD, Inc. Pharmaceuticals: MajorHealth Technology Manufactures women’s healthcare products | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
